New e-newsletter will provide updates on rare CNS tumours
A new e-newsletter has been launched by NCI-CONNECT, part of the National Cancer Institute (NCI) Centre for Cancer Research in the USA.
The aim of the e-newsletter is to bring together expert news and latest updates regarding research into rare brain and spine tumours, their treatments, clinical trials etc.
NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) aims to advance the understanding of rare adult central nervous system (CNS) cancers. They are starting with 12 specific types, including ependymoma, medulloblastoma, meningioma, oligodendroglioma and primitive neuro-ectodermal tumours (PNETs).
You can read more about NCI-CONNECT here and subscribe to their e-news on this page.
You can also subscribe to our weekly e-news bulletin, which will bring you all of our news on our research, events, campaigns and appeals.
- Brain cancer dataset now available free to researchers worldwide
- “No evidence of improved survival” with bevacizumab (Avastin) in patients with first recurrence of grade II or III glioma, without 1p/19q co-deletion